Nofi Michael 4
4 · Edgewise Therapeutics, Inc. · Filed Nov 13, 2025
Insider Transaction Report
Form 4
Nofi Michael
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2025-11-10+43,750→ 43,750 totalExercise: $0.00Exp: 2035-11-10→ Common Stock (43,750 underlying) - Award
Stock Options (Right to buy)
2025-11-10+262,500→ 262,500 totalExercise: $18.28Exp: 2035-11-10→ Common Stock (262,500 underlying)
Footnotes (2)
- [F1]Restricted Stock Units ("RSUs") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on November 10, 2026.
- [F2]1/4th of the shares subject to the option become vested and exercisable on November 10, 2026 and 1/48th of the shares subject to the option continue to vest each month thereafter, subject to the Reporting Person continuing as a service provider through each vest date.